Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/25463f045f454089abc25f6e7b64cc74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25463f045f454089abc25f6e7b64cc74
record_format dspace
spelling oai:doaj.org-article:25463f045f454089abc25f6e7b64cc742021-12-02T16:17:27ZInhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA10.1038/s42003-021-02381-x2399-3642https://doaj.org/article/25463f045f454089abc25f6e7b64cc742021-07-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02381-xhttps://doaj.org/toc/2399-3642Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing MDSC and Treg infiltration, while the Kras vaccine induced CD4+ effector T cell expansionJing PanYao ChenQi ZhangAchia KhatunKatie PalenGang XinLi WangChuanjia YangBryon D. JohnsonCharles R. MyersShizuko SeiRobert H. ShoemakerRonald A. LubetYian WangWeiguo CuiMing YouNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Jing Pan
Yao Chen
Qi Zhang
Achia Khatun
Katie Palen
Gang Xin
Li Wang
Chuanjia Yang
Bryon D. Johnson
Charles R. Myers
Shizuko Sei
Robert H. Shoemaker
Ronald A. Lubet
Yian Wang
Weiguo Cui
Ming You
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
description Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing MDSC and Treg infiltration, while the Kras vaccine induced CD4+ effector T cell expansion
format article
author Jing Pan
Yao Chen
Qi Zhang
Achia Khatun
Katie Palen
Gang Xin
Li Wang
Chuanjia Yang
Bryon D. Johnson
Charles R. Myers
Shizuko Sei
Robert H. Shoemaker
Ronald A. Lubet
Yian Wang
Weiguo Cui
Ming You
author_facet Jing Pan
Yao Chen
Qi Zhang
Achia Khatun
Katie Palen
Gang Xin
Li Wang
Chuanjia Yang
Bryon D. Johnson
Charles R. Myers
Shizuko Sei
Robert H. Shoemaker
Ronald A. Lubet
Yian Wang
Weiguo Cui
Ming You
author_sort Jing Pan
title Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
title_short Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
title_full Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
title_fullStr Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
title_full_unstemmed Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
title_sort inhibition of lung tumorigenesis by a small molecule ca170 targeting the immune checkpoint protein vista
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/25463f045f454089abc25f6e7b64cc74
work_keys_str_mv AT jingpan inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT yaochen inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT qizhang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT achiakhatun inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT katiepalen inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT gangxin inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT liwang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT chuanjiayang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT bryondjohnson inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT charlesrmyers inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT shizukosei inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT roberthshoemaker inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT ronaldalubet inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT yianwang inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT weiguocui inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
AT mingyou inhibitionoflungtumorigenesisbyasmallmoleculeca170targetingtheimmunecheckpointproteinvista
_version_ 1718384219662581760